as on October 21, 2025 at 1:29 am IST
Day's Low
Day's High
6.43%
Downside
4.37%
Upside
52 Week's Low
52 Week's High
58.61%
Downside
168.64%
Upside
Check Qualigen Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.4M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.58
Industry PE ratio
0PEG Ratio
0EBITDA
-6.9M
Revenue (TTM)
5.0M
Profit Margin
0.00%
Return On Equity TTM
-841.66%
Track how Qualigen Therapeutics Inc P/E has moved over time to understand its valuation trends.
Qualigen Therapeutics Inc in the last 5 years
Lowest (-98.55x)
December 31, 2021
Industry (0.00x)
October 21, 2025
Today (0.58x)
October 21, 2025
Highest (182.95x)
September 30, 2021
Today’s Price to Earnings Ratio: 0.58x
Compare market cap, revenue, PE, and other key metrics of Qualigen Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $7.4M | -99.82% | 0.58 | 0.00% | |
BUY | $35.5B | 359.02% | -16.34 | -259.82% | |
BUY | $63.1B | 259.92% | -505.15 | -12.96% | |
BUY | $106.9B | 98.27% | 29.67 | 31.86% | |
BUY | $61.3B | 0.76% | 14.58 | 31.37% |
The Qualigen Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Qualigen Therapeutics Inc investment value today
Current value as on today
₹47,384
Returns
Returns from Qualigen Therapeutics Inc Stock
Dollar Returns*
₹4,730 (+4.73%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Qualigen Therapeutics Inc. Average target price of $5
Get share price movements and forecasts by analysts on Qualigen Therapeutics Inc.
What analysts predicted
22.2%UPSIDE
Target Price
$5
Current Price
$3.89
Analyzed by
7 Analysts
Target
$5.00
Qualigen Therapeutics Inc target price $5, a slight upside of 22.2% compared to current price of $3.89. According to 7 analysts rating.
Investment in Qualigen Therapeutics Inc Shares on INDmoney has grown by 1010.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:1010.00% versus previous 30 day period
Search interest for Qualigen Therapeutics Inc Stock has increased by 630% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:630% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 21 September
Mon, 06:29 AM
-Faraday Future's YT Jia invests $4 million in Qualigen Therapeutics, acquiring about 7% of common stock.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, QLGN stock has moved up by 38.4%
Against Peers
In the last 1 year, Insmed Incorporated has given 132.3% return, outperforming this stock by 189.2%
Against Peers
In the last 3 years, Insmed Incorporated has given 809.6% return, outperforming this stock by 906.4%
Revenue Fall
Revenue is down for the last 2 quarters, 7.94M → 2.23M (in $), with an average decrease of 71.8% per quarter
Profit Down
Netprofit is down for the last 2 quarters, -855.82K → -1.68M (in $), with an average decrease of 96.9% per quarter
Organisation | Qualigen Therapeutics Inc |
Headquarters | 5857 Owens Avenue, Carlsbad, CA, United States, 92008 |
Industry | Health Technology |
CEO | Mr. Kevin A. Richardson II |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Kevin A. Richardson II | Interim CEO, Chief Accounting Officer & Chairman of the Board |
Mr. Michael S. Poirier | Chief Operating Officer |
Mr. Christopher L. Lotz | VP of Finance & Corporate Secretary |
Mr. Jiawei Wang | Co-Chief Executive Officer |
Mr. Koti Meka | Chief Financial Officer |
Qualigen Therapeutics Inc share price today is $3.89 as on at the close of the market. Qualigen Therapeutics Inc share today touched a day high of $4.06 and a low of $3.64.
Qualigen Therapeutics Inc share touched a 52 week high of $10.45 on and a 52 week low of $1.61 on . Qualigen Therapeutics Inc stock price today i.e. is closed at $3.89,which is 62.78% down from its 52 week high and 141.61% up from its 52 week low.
Qualigen Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Qualigen Therapeutics Inc (QLGN) shares with as little as ₹87.9 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.00 in Qualigen Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Qualigen Therapeutics Inc share’s latest price of $3.89 as on October 21, 2025 at 1:29 am IST, you will get 2.5707 shares of Qualigen Therapeutics Inc. Learn more about
fractional shares .
Qualigen Therapeutics Inc stock has given -99.82% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?